Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
June 13, 2024 19:58 ET
|
Opthea Limited
Fully underwritten Retail Entitlement Offer to raise a further approximately A$55.9m (US$36.9m1) will open on 19 June 2024 and close at 5:00 pm (Melbourne time) on 10 July 2024 MELBOURNE,...
Projet Moblan : les forages révèlent d’autres intersections de lithium à haute teneur
June 13, 2024 10:44 ET
|
Sayona Mining
Les derniers résultats de 34 nouveaux forages totalisant 7 853 mètres pour le projet de lithium Moblan de Sayona, Québec, Canada, avec les points forts suivants : Pegmatites de la zone sud (Est): ...
Moblan drilling reveals further high-grade lithium intersections
June 13, 2024 10:44 ET
|
Sayona Mining
• All assay results of the 2023 drilling campaign are now complete, validated and released. New 3D geological modelling is underway to consider all 2023.
Halleck Creek Project Update
June 13, 2024 08:03 ET
|
American Rare Earths
Highlights 2,470 m drilling program to commence in July 2024 in the Cowboy State Mine area to upgrade resources and advance mine planning work for prefeasibility analysis.New Research and Development...
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
June 12, 2024 19:22 ET
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
Recce Pharmaceuticals Completes Dosing Additional Cohort in Phase I/II UTI/Urosepsis Rapid Infusion Trial
June 12, 2024 08:00 ET
|
Recce Pharmaceuticals
SYDNEY, June 12, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd. (ASX:RCE, FSE:R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced it completed...
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
June 11, 2024 21:13 ET
|
Opthea Limited
Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2...
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
June 10, 2024 09:05 ET
|
ResMed Inc.
ResMed-supported research presented at SLEEP2024 demonstrates the effectiveness and value of positive airway pressure (PAP) treatment for OSA.
Sezzle Announces Resignation of Paul Purcell from its Board of Directors and Postpones Annual Meeting of Stockholders
June 07, 2024 07:02 ET
|
Sezzle
Minneapolis, MN, June 07, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Sezzle today announced that Paul Purcell resigned from its Board of Directors on June 6, 2024, and...
5E Advanced Materials to Hold Stockholder Call June 6, 2024
June 06, 2024 17:01 ET
|
5E Advanced Materials, Inc.
HESPERIA, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical...